No Kings protests return to New York City for third time as nationwide mobilisation targets Trump administration policies
A small imaging trial could reshape how brain metastases are detected and Radiopharm Theranostics is betting on it (ASX: RAD)
Seeing Machines (AIM: SEE) reports 33% royalty growth and 4.8 million cars on road as GSR countdown intensifies
Read More 2 minute read Pharma Industry News Race Oncology doses first patient in phase 1b/2 AML trial of FluCloZan Race Oncology has dosed the first patient in the phase 1b/2 trial of its Zantrene (bisantrene dihydrochloride) in… bySrinathAugust 9, 2021
